A faculty of global experts
The webcasts will bring together a faculty of global experts who have used GW CBD in the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
Prof. Dr.
Selim Benbadis
Prof. Dr.
Ulrich Brandl
Prof. Dr.
Richard FM Chin
Prof. Dr.
Angela M Kaindl
Prof. Dr.
Andreas Schulze-Bonhage
Prof. Dr.
Bernhard Steinhoff
Prof. Dr.
Elizabeth Thiele
Prof. Dr.
Sameer M Zuberi
PhD
Nick Jones
Selim Benbadis is Professor of Neurology at the University of South Florida and is Director of the University of South Florida/Tampa General Hospital Comprehensive Epilepsy Program. He has authored more than 100 articles and book chapters and serves on several editorial boards.
Ulrich Brandl is Director of the Department of Neuropaediatrics, University Hospital Jena, Germany, where he also serves as Chairman of the Ethics Committee.
Richard Chin is Professor of Paediatric Neurology and Clinical Epidemiology, and the Director of the Muir Maxwell Epilepsy Centre, at The University of Edinburgh, UK. He is an Honorary Consultant Paediatric Neurologist at the Royal Hospital for Sick Children (Edinburgh).
Angela Kaindl is Director of the Department of Pediatric Neurology and the Center for Chronically Sick Children at Charité – Universitätsmedizin Berlin. She is also Principal Investigator at the Charité Institute of Cell Biology and Neurobiology.
Andreas Schulze-Bonhage is Medical Director at the Freiburg Epilepsy Center, University of Freiburg, and President of the German Society of Epileptology. He is author of more than 340 peer-reviewed publications, has been active as a Principal Investigator in 40 multicentre clinical trials, and receives research funding from the EU, German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft, and the National Institutes of Health.
Bernhard Steinhoff is Professor of Neurology and Clinical Neurophysiology at the University of Freiburg and is Medical Director of the Epilepsy Centre Kork. He is a past president of the German Society of Epileptology and author of numerous peer-reviewed papers and book articles.
Elizabeth Thiele is Director of the Pediatric Epilepsy Service at Massachusetts General Hospital, Boston, MA, USA, and is Professor of Neurology at the Harvard Medical School. She organised and established the Herscot Center for Tuberous Sclerosis Complex and a ketogenic diet clinic to treat and manage patients with epilepsy.
Sameer Zuberi is Consultant Paediatric Neurologist at the Royal Hospital for Children and Honorary Professor of Paediatric Neurology in the University of Glasgow. He leads the Paediatric Neurosciences Research Group and is clinical lead of the Scottish National Genetic Epilepsy Service. His other roles include President of the European Paediatric Neurology Society, Editor-in-Chief of the European Journal of Paediatric Neurology, past Chair of the International League Against Epilepsy (ILAE) Commission on Classification & Terminology (2013-17) and ILAE Nosology & Definitions Task Force Member.
Nick Jones is Director of Regulatory Affairs at GW Pharmaceuticals Ltd and has 13 years of cannabinoid experience, including a GW-funded PhD in the field of pharmacology elucidating the non-clinical anticonvulsant potential of CBD for the treatment of epilepsies. Nick transitioned to Global Regulatory Affairs after 8 years in the Preclinical Department at GW directing development programmes and overseeing operations.
Full-time employee of GW Pharmaceuticals
© Copyright GW Pharmaceuticals 2020
This website is intended for healthcare professionals only. If you are not a healthcare professional, please visit www.gwpharm.co.uk
VV-MED-16326
Date of Preparation: December 2020
Personal info *
Webcast info
Legal info
